Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection-Reference-Cited by-同舟云学术

Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection

Published:2012-08-23 Issue:2 Volume:107 Page:148-154
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Tsai Hsiang-Lin,Yeh Yung-Sung,Chang Yu-Tang,Yang I-Ping,Lin Chih-Hung,Kuo Chao-Hung,Juo Suh-Hang,Wang Jaw-Yuan

Funder

Biosignature in Colorectal Cancers, Academia Sinica, Taiwan, an Excellence for Cancer Research Center

Kaohsiung Medical University Hospital

National Science Council of the Republic of China NSC

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.23243/fullpdf

Reference30 articles.

1. Angiogenesis in cancer and other diseases;Carmeliet;Nature,2000

2. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer;Vermeulen;Br J Cancer,1999

3. Tumor microvessel density and prognosis in node-negative breast cancer;Medri;Int J Cancer,2000

4. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer;Zafirellis;J Surg Res,2008

5. Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression;Lin;Proc Natl Acad Sci USA,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of Cyclin D1 Expression in Small Intestinal Adenocarcinoma;Cancers;2023-10-18

2. Prognostic Potential of Cyclin D1 Expression in Colorectal Cancer;Journal of Clinical Medicine;2023-01-10

3. Anastomosing Haemangioma: Report of Three Cases With Molecular and Immunohistochemical Studies and Comparison With Well-Differentiated Angiosarcoma;Pathology and Oncology Research;2022-08-01

4. Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance;Cell Death & Disease;2021-10

5. Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer;Cancers;2021-07-14